Physiological basis for xenotransplantation from genetically modified pigs to humans
Physiological Reviews · 01.07.2024 · 104 (3) · 1409-1459
DOI: 10.1152/physrev.00041.2023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Reviews, erschienen am 01.07.2024. Verfasst von Leigh Peterson und 10 weiteren Autor:innen. Beteiligte Einrichtung: United Therapeutics Corporation, Silver Spring, Maryland, United States. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Animals, Genetically Modified. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The collective efforts of scientists over multiple decades have led to advancements in molecular and cellular biology-based technologies including genetic engineering and animal cloning that are now being harnessed to enhance the suitability of pig organs for xenotransplantation into humans. Using organs sourced from pigs with multiple gene deletions and human transgene insertions, investigators have overcome formidable immunological and physiological barriers in pig-to-nonhuman primate (NHP) xenotransplantation and achieved prolonged pig xenograft survival. These studies informed the design of Revivicor’s (Revivicor Inc, Blacksburg, VA) genetically engineered pigs with 10 genetic modifications (10 GE) (including the inactivation of 4 endogenous porcine genes and insertion of 6 human transgenes), whose hearts and kidneys have now been studied in preclinical human xenotransplantation models with brain-dead recipients. Additionally, the first two clinical cases of pig-to-human heart xenotransplantation were recently performed with hearts from this 10 GE pig at the University of Maryland. Although this review focuses on xenotransplantation of hearts and kidneys, multiple organs, tissues, and cell types from genetically engineered pigs will provide much-needed therapeutic interventions in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- United Therapeutics Corporation, Silver Spring, Maryland, United States.
- Imperial College London, London, United Kingdom.
- Department of Surgery, Division of Transplantation, Johns Hopkins Medicine, Baltimore, Maryland, United States.
- University of Maryland Medical Center, Baltimore, Maryland, United States.
- J. Craig Venter Institute, Rockville, Maryland, United States.
- Department of Biochemistry, Gdańsk Medical University, Gdańsk, Poland.
ORCID-Profile: Leigh Peterson, Magdi H Yacoub, David Ayares, Kazuhiko Yamada, Daniel Eisenson, Bartley P Griffith, Muhammad M Mohiuddin, Willard Eyestone, J Craig Venter, Ryszard T Smolenski, Martine Rothblatt
Zitieren
APA
Peterson, L., Yacoub, M. H., Ayares, D., Yamada, K., Eisenson, D., Griffith, B. P., Mohiuddin, M. M., Eyestone, W., Venter, J. C., Smolenski, R. T., & Rothblatt, M. (2024). Physiological basis for xenotransplantation from genetically modified pigs to humans. Physiological Reviews, 104(3), 1409-1459. https://doi.org/10.1152/physrev.00041.2023
Vancouver
Peterson L, Yacoub MH, Ayares D, Yamada K, Eisenson D, Griffith BP, et al. Physiological basis for xenotransplantation from genetically modified pigs to humans. Physiological Reviews. 2024;104(3):1409-1459. doi:10.1152/physrev.00041.2023
BibTeX
@article{Peterson2024,
author = {Peterson, Leigh and Yacoub, Magdi H and Ayares, David and Yamada, Kazuhiko and Eisenson, Daniel and Griffith, Bartley P and Mohiuddin, Muhammad M and Eyestone, Willard and Venter, J Craig and Smolenski, Ryszard T and Rothblatt, Martine},
title = {Physiological basis for xenotransplantation from genetically modified pigs to humans},
journal = {Physiological Reviews},
year = {2024},
volume = {104},
number = {3},
pages = {1409--1459},
doi = {10.1152/physrev.00041.2023}
}
EUVIMED